Please feel free to forward to fellow researchers and share news of our journal | Dear Colleague, We are delighted to announce the publication of Volume 5, Issue 2 of our Kidney Cancer journal. This issue includes one review article, one research article, two systematic reviews, and a case report. From the editor of our regular journal section, there is also a new Clinical Trials Corner contribution. View all the open access content via the links below. | Call for Papers As a member of our community, we would like to invite you to submit your own research articles to the journal, which offers contributing authors many benefits: • First class Editorial Board • Rigorous peer review and speedy manuscript processing • Rapid online publication (pre-press) on acceptance • The first volumes of the journal freely available to all readers • Articles accepted this year will be published open access with no article processing fee Submit your manuscript online via msTracker View detailed Instructions to Authors Aims and Scope Kidney Cancer is an international, multidisciplinary journal that provides an invaluable and indispensable platform for the many collaborative, transdisciplinary, and translational efforts to help treat and finally cure this malignancy. Best wishes, Primo N. Lara Jr, MD UC Davis Comprehensive Cancer Center Sacramento, CA, USA Email: kca@iospress.com Peter Mulders, MD, PhD Radboud UMC Nijmegen, The Netherlands Email: kca@iospress.com Editors-in-Chief Sign up now for Kidney Cancer news Join the conversation at: twitter.com/KCA_Journal | All articles are freely available online for all to read, download and share. REVIEW ARTICLE Nivolumab: 5 Years Since FDA Approval of the First Checkpoint Inhibitor for Renal Cell Carcinoma Tsimafeyeu, Ilya RESEARCH ARTICLE Twitter as a Tool to Spread Communication Regarding Genitourinary Cancers During the COVID-19 Pandemic Salgia, Sabrina | Salgia, Nicholas | Prajapati, Sweta | Seghal, Ishaan | Bautista, Frank | Ruel, Nora | Salgia, Meghan | Salgia, Deborah A. | Salgia, Ravi | Pal, Sumanta K. SYSTEMATIC REVIEWS PBRM1 Mutations as a Predictive Biomarker for Immunotherapy in Metastatic Renal Cell Carcinoma: A Systematic Review Dias Carneiro, André Paternò Castello | Marques Monteiro, Fernando Sabino | Soares, Andrey Impact of SARS-CoV-2 Pandemic on Kidney Cancer Management Bersanelli, Melissa | Porta, Camillo CASE REPORT Renal Cancer Without Primary Cancer in the Kidney: Extra-Renal TFE3 Translocation Associated Renal Cell Carcinoma Petrinec, Benjamin | Vargas, Bryan Morales | Harik, Lara R. | Master, Viraj A. OTHER Clinical Trials Corner: A New Look at Cytoreductive Nephrectomy Parikh, Mamta | Most Viewed Kidney Cancer Articles in Q2 2021 Listing articles published in 2020 and 2021 so you can read the most popular recent content Adjuvant Therapy in Renal Cell Carcinoma: Current Status and Future Directions (Review Article in Vol.5, Iss.1, 2021) Kazarian, Austin G. | Chawla, Neal S. | Muddasani, Ramya | Pal, Sumanta K. Cost-Effectiveness of Immunotherapy Treatments for Renal Cell Carcinoma: A Systematic Review (Systematic Review in Vol.5, Iss.1, 2021) Philip, Errol J. | Zhang, Sylvia | Tahir, Peggy | Kim, Daniel | Wright, Francis | Bell, Alexander | Borno, Hala T. Real-Word Experience of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis) (Research Article, Vol.5, Iss.1, 2021) Zhang, Hanbo | Basappa, Naveen S. | Ghosh, Sunita | Joy, Isaiah | Lalani, Aly-Khan A. | Hansen, Aaron R. | Heng, Daniel Y.C. | Castonguay, Vincent | Kollmannsberger, Christian K. | et al. PBRM1 Mutations as a Predictive Biomarker for Immunotherapy in Metastatic Renal Cell Carcinoma: A Systematic Review (Systematic Review in Vol.5, Iss.2, 2021) Dias Carneiro, André Paternò Castello | Marques Monteiro, Fernando Sabino | Soares, Andrey Renal Cell Carcinoma with Inferior Vena Cava Extension: Can Classification Be Optimized to Predict Perioperative Outcomes? (Short Communication in Vol.4, Iss.2, 2020) Leibovich, Bradley C. | Lohse, Christine M. | Cheville, John C. | Potretzke, Theodora A. | Tsivian, Matvey | Shah, Paras H. | Boorjian, Stephen A. | Thompson, R. Houston | Lyon, Timothy D. | Kidney Cancer Association News Austin, TX | Nov 5 & 6, 2021 | In-Person & Virtual The Kidney Cancer Association is pleased to announce the International Kidney Cancer Symposium (IKCS) will be held in Austin, TX in November and will be welcoming delegates in-person and virtually. It is an opportunity for physicians, researchers, academics, and industry professionals from across the globe to join together and exchange ideas which will direct the future of kidney cancer research and treatment in the ultimate pursuit of a cure. The IKCS event takes place across two days, on November 5 and 6, 2021. There will be 50+ experts presenting over the course of the conference covering the topics listed below, and more. Topics: * The Role of Perioperative Therapy in RCC * Multimodality Perspectives on Clinical Trial Development * Non-clear cell RCC * Translational Cancer Insights * Mentoring the Next Generation and Networking * Impact of Adjuvant IO on 1st Line Therapy * Legislative Advocacy, Funding, and the Patient Experience | Registration is open: Simply head to the IKCS website to book your place at this event, with early-bird rates available until September 29, 2021. Register now! | Presentations from EIKCS 2021 can be viewed via the website here | Please Share Kidney Cancer News With Your Colleagues Help Spread the News! | If you know of any colleagues or fellow researchers who are not yet signed up to receive the newsletter, we invite you to share this mailing with them. Click on the visual or access the sign-up link here. Kidney Cancer has an active social media presence. If you are not yet interacting with the journal on social media, why not take the time today to follow us on Twitter? Be part of the discussion! | You are receiving this mailing as you are signed up to receive news from KCA. You can unsubscibe or alter your preferences at any time by clicking the links below. | |